# Single and Multiple Dose Pharmacokinetics of Sufentanil NanoTab

> **NCT01761565** · PHASE1 · COMPLETED · sponsor: **Talphera, Inc** · enrollment: 40 (actual)

## Conditions studied

- Plasma Concentrations

## Interventions

- **DRUG:** Single dose of SUF NT 15 mcg
- **DRUG:** 40 consecutive doses of SUF NT 15 mcg taken every 20 minutes

## Key facts

- **NCT ID:** NCT01761565
- **Lead sponsor:** Talphera, Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-01
- **Primary completion:** 2013-02
- **Final completion:** 2013-02
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2015-10-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01761565

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01761565, "Single and Multiple Dose Pharmacokinetics of Sufentanil NanoTab". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01761565. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*